Aug 20, 2025 9:25am EDT Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
Aug 19, 2025 6:00am EDT Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
Apr 02, 2025 6:00am EDT Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
Mar 27, 2025 6:00am EDT Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
Mar 17, 2025 6:45am EDT Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
Feb 10, 2025 6:00am EST Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
Jan 29, 2025 6:00am EST Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe